CAMP4 Therapeutics Receives Australian Clearance for First-in-Human CMP-002 Trial
CAMBRIDGE, Mass., July 27, 2026 CAMP4 Therapeutics announced that it has received regulatory clearance from Australia’s Therapeutic Goods Administration...
regulatory clearance
Advertisement
FDA Clears Neurophet AQUA AD Plus in Alzheimer’s AI
Seoul, South Korea — February 6, 2026 Neurophet has announced that the U.S. Food and Drug Administration (FDA) has...
BlueOcean Wins FDA 510(k) Clearance for Excelsior Fixation System
DENVER, COLORADO | January 26, 2026 — BlueOcean Global has received FDA 510(k) clearance for its Excelsior™ External Fixation...
Advertisement
